JMS Investor Relations

JMS Co.,Ltd. engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals in Japan, North America, Europe, China, South Korea, Thailand, and internationally. It offers infusion and nutrition solutions, which includes needless access port, closed drug mixing and infusion system, infusion pump, and oral and enteral nutrition system for treatment and laboratory testing; and dialysis solutions including dialysis equipment for hemodialysis, peritoneal dialysis solution, and APD equipment that automatically performs the injection and discharge of peritoneal dialysis solution. It also provides surgical treatment solution comprising products that are used in cardiac surgery and cardiovascular internal medicine, such as membrane oxygenator and cardiopulmonary blood tubing sets. In addition, the company offers blood management and cell therapy solutions, which includes serum collection sets and blood bags. Further, it provides logistics and other equipment; and offers maintenance works and sanatorium services. The company was incorporated in 1947 and is headquartered in Hiroshima, Japan.

Read Less